ReviewIET nanobiotechnology2018
Metallic nanoparticle synthesised by biological route: safer candidate for diverse applications.
Review in IET nanobiotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Synthesis of ecologically effective adsorbent from theba pisana snails for enhanced adsorption of Pb and Fe.Scientific reports · 2025Article
- Nanoscale Interaction Mechanisms of Antiviral Activity.ACS pharmacology & translational science · 2023Review
- Time-Dependent Size and Shape Evolution of Gold and Europium Nanoparticles from a Bioproducing Microorganism, a Cyanobacterium: A Digitally Supported High-Resolution Image Analysis.Nanomaterials (Basel, Switzerland) · 2022Article
- Mechanism and Antibacterial Activity of Gold Nanoparticles (AuNPs) Functionalized with Natural Compounds from Plants.Pharmaceutics · 2022Review
- Complete Genome Sequence of Enterobacter xiangfangensis Pb204, a South African Strain Capable of Synthesizing Gold Nanoparticles.Microbiology resource announcements · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biological synthesis of nanoparticles (NPs) involves greater prospect; however, a detailed review is required for ecofriendly, faster and stable NP formulation in large scale for different commercial applications. The present article highlighted recent updates on biological route of single and bimetallic NP synthesis wherein the chemical reducing agents are eliminated and biological entities are utilised to convert metal ions to NPs. Application of the biological reducing agents ranging from bacteria to fungi and even natural plant extracts have emerged as eco-friendly and cost-effective routes for the synthesis of metal nanomaterials. Potential applications of such NPs, a wide range of analytical techniques used for characterisation and factors influencing the synthesis of NPs are focused. Further, elucidation of the mechanisms associated with the NP formation using microorganisms, as well as plant-based materials are analysed which would be helpful for wide range of readers in the field of NP research for future selection and commercial implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.